FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 344:1393-1396 May 3, 2001 Number 18 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Exner, D. V. Related Article by Yancy, C. W.

All physicians recognize that individual patients respond differently to medications, so that at so-called standard doses, a drug may have toxic effects in some patients but fail to produce the expected therapeutic effect in others. Our lack of understanding of all the factors determining such variability among individual patients is perplexing to both physicians and their patients and limits physicians' ability to individualize therapy. Consequently, prescribing drugs is an iterative process, in which physicians initially prescribe a standard dose of medication and then adjust the dose or choice of medication in response to the observed toxic or therapeutic response. For . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Lillquist, E., Sullivan, C. A. (2006). Legal Regulation of the Use of Race in Medical Research. J Law Med Ethics 34: 535-551  
• Harty, L., Johnson, K., Power, A. (2006). Race and ethnicity in the era of emerging pharmacogenomics.. J Clin Pharmacol 46: 405-407 [Abstract] [Full Text]  
• Emily, M., Francois, O. (2006). Conditional Coalescent Trees With Two Mutation Rates and Their Application to Genomic Instability. Genetics 172: 1809-1820 [Abstract] [Full Text]  
• Ng, C. V. (2005). Hypersensitivity Reactions to Oxaliplatin in Two Asian Patients. The Annals of Pharmacotherapy 39: 1114-1118 [Abstract] [Full Text]  
• Kim, K., Johnson, J. A., Derendorf, H. (2004). Differences in Drug Pharmacokinetics Between East Asians and Caucasians and the Role of Genetic Polymorphisms. J Clin Pharmacol 44: 1083-1105 [Abstract] [Full Text]  
• Condit, C. M., Parrott, R. L., Harris, T. M., Lynch, J., Dubriwny, T. (2004). The Role of "Genetics" in Popular Understandings of Race in the United States. Public Understanding of Science 13: 249-272 [Abstract]  
• Roden, D. M. (2003). Cardiovascular Pharmacogenomics. Circulation 108: 3071-3074 [Full Text]  
• Lim, E. H., Lim, R. S. C., Wu, T. S., Kong, H. L. (2003). Oxaliplatin/Fluorouracil/Leucovorin in Advanced Colorectal Carcinoma: an Asian Experience. The Annals of Pharmacotherapy 37: 1909-1912 [Abstract] [Full Text]  
• Helliwell, P. S., Ibrahim, G. (2003). Ethnic differences in responses to disease modifying drugs. Rheumatology (Oxford) 42: 1197-1201 [Abstract] [Full Text]  
• Bonds, D. E., Zaccaro, D. J., Karter, A. J., Selby, J. V., Saad, M., Goff, D. C. Jr (2003). Ethnic and Racial Differences in Diabetes Care: The Insulin Resistance Atherosclerosis Study. Diabetes Care 26: 1040-1046 [Abstract] [Full Text]  
• Goh, B.-C., Lee, S.-C., Wang, L.-Z., Fan, L., Guo, J.-Y., Lamba, J., Schuetz, E., Lim, R., Lim, H.-L., Ong, A.-B., Lee, H.-S. (2002). Explaining Interindividual Variability of Docetaxel Pharmacokinetics and Pharmacodynamics in Asians Through Phenotyping and Genotyping Strategies. JCO 20: 3683-3690 [Abstract] [Full Text]  
• Kahn, D. F., Duffy, S. J., Tomasian, D., Holbrook, M., Rescorl, L., Russell, J., Gokce, N., Loscalzo, J., Vita, J. A. (2002). Effects of Black Race on Forearm Resistance Vessel Function. Hypertension 40: 195-201 [Abstract] [Full Text]  
• Kennedy, H. L., Rosenson, R. S. (2002). Physicians' interpretation of "class effects": A need for thoughtful re-evaluation. J Am Coll Cardiol 40: 19-26 [Abstract] [Full Text]  
• Robertson, J. A., Brody, B., Buchanan, A., Kahn, J., McPherson, E. (2002). Pharmacogenetic Challenges For The Health Care System. Health Aff (Millwood) 21: 155-167 [Abstract] [Full Text]  
• Bovet, P., Paccaud, F., McLeod, H. L., Masoudi, F. A., Havranek, E. P., Ofili, E., Flack, J., Gibbons, G., Exner, D. V., Domanski, M. J., Cohn, J. N., Schwartz, R. S. (2001). Race and Responsiveness to Drugs for Heart Failure. NEJM 345: 766-768 [Full Text]  
• (2001). Race and Response to Therapies. Journal Watch Cardiology 2001: 2-2 [Full Text]  
• (2001). Racial Differences in Response to Heart Failure Therapy?. JWatch General 2001: 1-1 [Full Text]